Stifel neutral on Incyte in premarket analyst action

|About: AmerisourceBergen Corp... (ABC)|By:, SA News Editor

CVS Health (NYSE:CVS) initiated with Market Perform rating and $58 (8% upside) price target at BMO. Share down a fraction premarket.

Incyte (NASDAQ:INCY) initiated with Hold rating and $82 (2% downside risk) price target at Stifel.

PTC Therapeutics (NASDAQ:PTCT) initiated with Outperform rating and $48 (24% upside) price target at Bernstein.

Seattle Genetics (NASDAQ:SGEN) initiated with Hold rating and $70 (13% downside risk) price target at Stifel.

AmerisourceBergen (NYSE:ABC) initiated with Buy rating at Guggenheim.

ArQule (NASDAQ:ARQL) initiated with Outperform rating and $9 (59% upside) price target at RBC.

Cardiovascular Systems (NASDAQ:CSII) downgraded to Underperform with a $42 (10% downside risk) price target. Shares down 3% premarket.

Eli Lilly (NYSE:LLY) downgraded to Neutral with a $127 (flat) price target at Guggenheim citing valuation and limited upside.

Subscribe for full text news in your inbox